小分子抑制剂靶向非经典细胞焦亡减轻LPS诱导角膜炎小鼠模型炎症
本研究探讨小分子细胞焦亡抑制剂J114能否抑制非经典细胞焦亡及其机制,并在LPS诱导的角膜炎小鼠模型中评估其体内治疗作用。体外实验显示J114通过阻断NLRP3-ASC相互作用抑制caspase-4/5/11及非经典NLRP3炎症小体活化,减少非经典细胞焦亡和炎性细胞因子释放;体内实验显示J114减轻LPS诱导的急性角膜炎临床表现、组织学紊乱和炎症反应。作者认为J114可能成为炎症性眼表疾病药物开发的潜在先导化合物。
要点
- J114通过阻断NLRP3-ASC相互作用抑制caspase-4/5/11及非经典NLRP3炎症小体活化。
- J114在体外抑制非经典细胞焦亡并减少炎性细胞因子释放。
- LPS诱导角膜炎小鼠模型中J114减轻临床表现、组织学紊乱和炎症反应。
核心结论
- J114能有效抑制LPS诱导的非经典细胞焦亡并揭示其机制。
- J114在LPS诱导的角膜炎小鼠模型中显示显著抗炎活性。
- 作者认为J114可能成为炎症性眼表疾病药物开发的潜在先导化合物。
研究设计与样本
- 体外实验使用人源或鼠源巨噬细胞,以胞内LPS刺激诱导非经典细胞焦亡活化。
- 体内实验采用LPS基质内注射诱导小鼠急性角膜炎模型。
- 通过临床评分、组织学观察、巨噬细胞定位和角膜焦亡标志物定量评估J114的治疗效果。
主要发现
- J114通过阻断NLRP3-ASC相互作用抑制caspase-4/5/11活化和非经典NLRP3炎症小体活化。
- J114显著抑制非经典细胞焦亡和炎性细胞因子释放。
- 体内实验中J114减轻LPS诱导的急性角膜炎临床表现和组织学紊乱,并缓解炎症反应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Pyroptosis, a novel proinflammatory programmed cell death, has been implicated in some ocular diseases. Of special note is the noncanonical pyroptosis that has recently been recognized to play a critical role in microbial keratitis. We previously discovered a new potent small molecular pyroptosis inhibitor, J114. In this investigation, we will explore whether J114 is able to inhibit the noncanonical pyroptosis and the underlying mechanism. Then a lipopolysaccharide (LPS)-induced keratitis mouse model will be used to evaluate the therapeutic effect of J114 in vivo. METHODS: In vitro, macrophages originating from humans or mice were stimulated with intracellular LPS to induce noncanonical pyroptosis activation. in vivo, acute keratitis in mouse was induced by LPS intrastromal injection. We verified the protective effect of J114 on noncanonical pyroptosis. Clinical scoring, histological observation, macrophage localization, and quantification of pyroptotic markers in the cornea were used to characterize the therapeutic effects. RESULTS: J114 substantially inhibited the noncanonical pyroptosis and the release of inflammatory cytokines by suppressing the activation of caspase-4/5/11 and the noncanonical NLRP3 inflammasome through blocking the NLRP3-ASC interaction. in vivo, J114 protected against LPS-induced noncanonical pyroptosis of acute keratitis, as manifested by alleviated clinical manifestations and histological disorders, and relieved inflammatory reactions. CONCLUSIONS: In this study, we found that J114 could efficiently inhibit LPS-induced noncanonical pyroptosis and revealed the underlying mechanism. This compound displayed significant anti-inflammatory activity in the LPS-induced keratitis mouse model. All the findings indicated that J114 could be a potential lead compound for drug development against inflammatory ocular surface diseases.
引用
- Zhang Y, Zhou N, Jiao Y, et al. Targeting Noncanonical Pyroptosis With a Small Molecular Inhibitor Alleviates Inflammation in the LPS-Induced Keratitis Mouse Model. Invest Ophthalmol Vis Sci. 2023. PMID: 36595275. doi:10.1167/iovs.64.1.1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。